(Q79429550)

English

Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study

scientific article published on 01 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

4

object named as

Franco Frati

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Giovanni Passalacqua

2

object named as

Giovanni Passalacqua

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Patrizia Berto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Claudio Ortolani

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Gianenrico Senna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Giorgio Walter Canonica

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Italian SPAI Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

97

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

615-621

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual immunotherapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhinitis as an independent risk factor for adult-onset asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects☆☆☆★Results from the European Community Respiratory Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Modelling in economic evaluation: an unavoidable fact of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ragweed immunotherapy in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961090-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)61090-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165269%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79429550&oldid=2110291098"